Paper698554
Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
Jarrett PE and 2 others. Br Med J, 1978. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Treatment of Raynaud's phenomenon by fibrinolytic enhancement. Papers, record 698554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolysis | Major topic |
| Raynaud Disease | Major topic |
| Stanozolol | Major topic |
| Adult | |
| Aged | |
| Blood Flow Velocity | |
| Body Temperature | |
| Female | |
| Hand | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14289442 | BLOOD VISCOSITY AND RAYNAUD'S DISEASE. | Lancet | 1965 | https://conductscience.org/library/papers/14289442 | PubMed |
| 4 | 837170 | Blood and vein-wall fibrinolytic activity in health and vascular disease. | Br Med J | 1977 | https://conductscience.org/library/papers/837170 | PubMed |
| 5 | 5429531 | Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus. | Lab Invest | 1970 | https://conductscience.org/library/papers/5429531 | PubMed |
| 6 | 5775073 | Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. | Br J Dermatol | 1969 | https://conductscience.org/library/papers/5775073 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8323396 | Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon. | Ann Rheum Dis | 1993 | https://conductscience.org/library/papers/8323396 | PubMed |
| 8079819 | The differential effects of stanozolol on human skin and synovial fibroblasts in vitro: DNA synthesis and receptor binding. | Agents Actions | 1994 | https://conductscience.org/library/papers/8079819 | PubMed |
| 7681375 | Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. | Drugs | 1993 | https://conductscience.org/library/papers/7681375 | PubMed |
| 7427564 | Treatment of vasospastic disease with prostaglandin E1. | Br Med J | 1980 | https://conductscience.org/library/papers/7427564 | PubMed |
| 7259326 | Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. | Ann Rheum Dis | 1981 | https://conductscience.org/library/papers/7259326 | PubMed |
| 6816332 | Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6816332 | PubMed |
| 6540787 | Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6540787 | PubMed |
| 6428575 | Systemic sclerosis: a collagen or microvascular disease? | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6428575 | PubMed |
| 6350584 | Systemic sclerosis--a microvascular disorder? | J R Soc Med | 1983 | https://conductscience.org/library/papers/6350584 | PubMed |
| 6229551 | Assessment of platelet function in patients with Raynaud's syndrome. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6229551 | PubMed |
| 2663416 | Management of Raynaud's phenomenon. Focus on newer treatments. | Drugs | 1989 | https://conductscience.org/library/papers/2663416 | PubMed |
| 2556901 | The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblasts in vitro. | Agents Actions | 1989 | https://conductscience.org/library/papers/2556901 | PubMed |
| 2467711 | Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. | BMJ | 1989 | https://conductscience.org/library/papers/2467711 | PubMed |
| 2383084 | Axillary vein thrombosis in adolescent onset systemic sclerosis. | Ann Rheum Dis | 1990 | https://conductscience.org/library/papers/2383084 | PubMed |
| 2285650 | Pathogenesis and treatment of Raynaud's phenomenon. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2285650 | PubMed |
| 1994867 | A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. | Ann Rheum Dis | 1991 | https://conductscience.org/library/papers/1994867 | PubMed |
| 1722967 | A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. | Ann Rheum Dis | 1991 | https://conductscience.org/library/papers/1722967 | PubMed |
| 1691027 | Raynaud's syndrome. | BMJ | 1990 | https://conductscience.org/library/papers/1691027 | PubMed |
| 1529798 | The differential responses of human skin and synovial fibroblasts to stanozolol in vitro: production of prostaglandin E2 and matrix metalloproteinases. | Agents Actions | 1992 | https://conductscience.org/library/papers/1529798 | PubMed |
| 1516602 | Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1516602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/698554
GET https://conductscience.org/api/papers/v1/698554/cited_by?page=2